These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome. Arduini A; Marasco E; Marucci G; Pardeo M; Insalaco A; Caiello I; Moneta GM; Prencipe G; De Benedetti F; Bracaglia C Pediatr Rheumatol Online J; 2019 May; 17(1):25. PubMed ID: 31118063 [TBL] [Abstract][Full Text] [Related]
5. Macrophage activation syndrome as a complication of rheumatologic disorders, a report from Iran. Assari R; Sadeghi P; Mirmohammadsadeghi A; Ebadi F; Ziaee V Reumatismo; 2020 Jan; 71(4):189-198. PubMed ID: 31995957 [TBL] [Abstract][Full Text] [Related]
6. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ravelli A; Minoia F; Davì S; Horne A; Bovis F; Pistorio A; Aricò M; Avcin T; Behrens EM; De Benedetti F; Filipovic L; Grom AA; Henter JI; Ilowite NT; Jordan MB; Khubchandani R; Kitoh T; Lehmberg K; Lovell DJ; Miettunen P; Nichols KE; Ozen S; Pachlopnik Schmid J; Ramanan AV; Russo R; Schneider R; Sterba G; Uziel Y; Wallace C; Wouters C; Wulffraat N; Demirkaya E; Brunner HI; Martini A; Ruperto N; Cron RQ; ; ; ; Arthritis Rheumatol; 2016 Mar; 68(3):566-76. PubMed ID: 26314788 [TBL] [Abstract][Full Text] [Related]
7. Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis. Reddy VV; Myles A; Cheekatla SS; Singh S; Aggarwal A Int J Rheum Dis; 2014 Mar; 17(3):261-7. PubMed ID: 24417800 [TBL] [Abstract][Full Text] [Related]
8. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus. Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530 [TBL] [Abstract][Full Text] [Related]
9. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ravelli A; Minoia F; Davì S; Horne A; Bovis F; Pistorio A; Aricò M; Avcin T; Behrens EM; De Benedetti F; Filipovic L; Grom AA; Henter JI; Ilowite NT; Jordan MB; Khubchandani R; Kitoh T; Lehmberg K; Lovell DJ; Miettunen P; Nichols KE; Ozen S; Pachlopnik Schmid J; Ramanan AV; Russo R; Schneider R; Sterba G; Uziel Y; Wallace C; Wouters C; Wulffraat N; Demirkaya E; Brunner HI; Martini A; Ruperto N; Cron RQ; ; ; ; Ann Rheum Dis; 2016 Mar; 75(3):481-9. PubMed ID: 26865703 [TBL] [Abstract][Full Text] [Related]
10. Validation of Classification Criteria of Macrophage Activation Syndrome in Japanese Patients With Systemic Juvenile Idiopathic Arthritis. Shimizu M; Mizuta M; Yasumi T; Iwata N; Okura Y; Kinjo N; Umebayashi H; Kubota T; Nakagishi Y; Nishimura K; Yashiro M; Yasumura J; Yamazaki K; Wakiguchi H; Okamoto N; Mori M Arthritis Care Res (Hoboken); 2018 Sep; 70(9):1412-1415. PubMed ID: 29195002 [TBL] [Abstract][Full Text] [Related]
11. Occult macrophage activation syndrome in systemic-onset juvenile idiopathic arthritic syndrome--a case report. Zeng P; Li F; Zeng H Acta Reumatol Port; 2013; 38(3):196-200. PubMed ID: 24149017 [TBL] [Abstract][Full Text] [Related]
12. Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis. Kostik MM; Dubko MF; Masalova VV; Snegireva LS; Kornishina TL; Chikova IA; Likhacheva TS; Isupova EA; Glebova NI; Kuchinskaya EM; Balbotkina EV; Buchinskaya NV; Kalashnikova OV; Chasnyk VG Semin Arthritis Rheum; 2015 Feb; 44(4):417-22. PubMed ID: 25300700 [TBL] [Abstract][Full Text] [Related]
13. Clinical features and correct diagnosis of macrophage activation syndrome. Cron RQ; Davi S; Minoia F; Ravelli A Expert Rev Clin Immunol; 2015; 11(9):1043-53. PubMed ID: 26082353 [TBL] [Abstract][Full Text] [Related]
14. Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers. Ruscitti P; Cipriani P; Ciccia F; Masedu F; Liakouli V; Carubbi F; Berardicurti O; Guggino G; Di Benedetto P; Di Bartolomeo S; Valenti M; Triolo G; Giacomelli R Autoimmun Rev; 2017 Jan; 16(1):16-21. PubMed ID: 27664384 [TBL] [Abstract][Full Text] [Related]
15. Macrophage Activation Syndrome in Adults: A Retrospective Case Series. Warmoth T; Ramesh M; Iwuji K; Pixley JS J Investig Med High Impact Case Rep; 2021; 9():23247096211026406. PubMed ID: 34180255 [TBL] [Abstract][Full Text] [Related]